Pharmacokinetics and Safety of AmBisome and DKF-5122

Clinical trial NCT05749380 · COMPLETED

Trial details

NCT number: NCT05749380
Sponsor: Dongkook Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Invasive Fungal Infections Neutropenic Fever

Start date: 2020-09-07
Primary completion: 2022-01-28
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.